KARYOPHARM THERAPEUTICS INC's ticker is and the CUSIP is 48576UAA4. A total of 12 filers reported holding KARYOPHARM THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,215,000 | -3.4% | 8,000,000 | 0.0% | 9.09% | +14.7% |
| Q2 2023 | $5,400,000 | -30.9% | 8,000,000 | -20.0% | 7.93% | +11.9% |
| Q1 2023 | $7,819,180 | +0.9% | 10,000,000 | 0.0% | 7.08% | +84.4% |
| Q4 2022 | $7,750,000 | -4.8% | 10,000,000 | 0.0% | 3.84% | +20.8% |
| Q3 2022 | $8,145,000 | +24.1% | 10,000,000 | +11.1% | 3.18% | +22.0% |
| Q2 2022 | $6,561,000 | -12.9% | 9,000,000 | 0.0% | 2.60% | -15.3% |
| Q1 2022 | $7,529,000 | +84.2% | 9,000,000 | +80.0% | 3.08% | +66.2% |
| Q4 2021 | $4,088,000 | – | 5,000,000 | – | 1.85% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Birch Grove Capital LP | 8,000,000 | $5,215,000 | 9.09% |
| BRAIDWELL LP | 65,976,000 | $40,943,996 | 1.29% |
| Context Capital Management, LLC | 21,494 | $13,329 | 1.07% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 30,500,000 | $20,663,750 | 0.86% |
| DAVIDSON KEMPNER CAPITAL MANAGEMENT LP | 25,000,000 | $15,264,731 | 0.24% |
| DeepCurrents Investment Group LLC | 4,250,000 | $2,700,994 | 0.12% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 7,500,000 | $4,654,419 | 0.02% |
| Verition Fund Management LLC | 1,359 | $843,381 | 0.01% |
| LAZARD ASSET MANAGEMENT LLC | 6,500,000 | $4,033 | 0.01% |
| BLB&B Advisors, LLC | 75,000 | $45,794 | 0.00% |